🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Acute Ischemic Stroke AIS

ACT-GLOBAL THROMBOLYSIS (ACT-WHEN-001) Domain Within the ACT-GLOBAL Adaptive Platform Trial-NCT06352632 NCT06320431Phase 324 sites📍 Sydney📍 Sydney📍 Melbourne University of Calgary · Tests: Tenecteplase Exploration of the Efficacy and Mechanism of Galantamine (an Extract From Lycoris Aurea) in Treating Ischemic Stroke NCT07003386Phase 2, Phase 31 site📍 Shanghai Shanghai Yueyang Integrated Medicine Hospital · Tests: Galantamine, Standard treatment for acute ischemic stroke Effect of Human Urinary Kallidinogenase on Inflammatory Factors in Acute Ischemic Stroke (KIF-AIS) NCT06696703NA1 site📍 Harbin First Affiliated Hospital of Harbin Medical University · Tests: Human urinary kininogenase(HUK), Placebo Safety and Efficacy Evaluation of the Ceretrieve Device in the Treatment of AIS Patients NCT06733246NA1 site📍 Heidelberg Ceretrieve Ltd. · Tests: Aspiration 0 Acute Ischemic Stroke in Patients With Active Cancer NCT07819526n/a1 site📍 Suita Osaka University FORWARD: Functional Outcomes in Real-World Treatment And Revascularization of Non-dominant and Distal M2 Occlusions NCT07749170n/a5 sites📍 Englewood📍 New Haven📍 Lexington Penumbra Inc. · Tests: Endovascular Thrombectomy, Medical Management A Multicentre, Randomised, Double-blind, Placebo-parallel Controlled Phase Ⅲ Clinical Trial Evaluating the Efficacy and Safety of BXOS110 Injection in the Treatment of Acute Ischaemic Stroke Within 3 Hours of Onset. NCT07520565Phase 39 sites📍 Hengshui📍 Daqing📍 Nanyang Biocells (Beijing) Biotech Co.,Ltd · Tests: BXOS110, placebo Safety and Efficacy of J147 in Acute Ischemic Stroke NCT07430917Phase 25 sites📍 Long Beach📍 Rockford📍 Albany Abrexa Pharmaceuticals, Inc. · Tests: J147 Emulsion for Injection, Placebo Evaluation of the CONDA Stent Retriever in Acute Ischemic Stroke NCT07174505NA2 sites📍 Budapest📍 Barcelona Anaconda Biomed S.L. · Tests: Mechanical Thrombectomy using the CONDA Stent Retriever One-Stop manaGemEnT For A Swift Initiation of Endovascular Therapy NCT07052045NA2 sites📍 Nuremberg📍 Basel Prof. Dr. Jan Liman · Tests: One Stop Management, Usual care management A Phase IIa Clinical Trial to Evaluate the Efficacy and Safety of Intravenous Infusion of hUC-MSCs in Patients With AIS NCT07084012Phase 21 site📍 Beijing Shenzhen Wingor Biotechnology Co., Ltd. · Tests: hUC-MSCs treatment (high dose), hUC-MSCs treatment (low dose), Placebo Treatment of Acute Ischemic Stroke (ReMEDy2 Trial) NCT05065216Phase 2, Phase 386 sites📍 Fairhope📍 Arcadia📍 Glendale DiaMedica Therapeutics Inc · Tests: Recombinant human tissue kallikrein, Placebo for DM199 Solution for Injection A Study to Evaluate the Intracranial Arterial Recanalization With Multiple Doses of LT3001 Drug Product in AIS Participant NCT07890298Phase 21 site📍 Taichung Lumosa Therapeutics Co., Ltd. · Tests: LT3001 Drug Product Study to Collect Real-world Performance and Safety Data on Penumbra System® in Population With Acute Ischemic Stroke (AIS). NCT07107022n/a12 sites📍 Nedlands📍 Kelowna📍 Toronto Penumbra Inc. · Tests: Penumbra System ® Acute Ischemic Stroke EndoVascular Therapy: a Multicenter REGISTRY Study NCT05864638n/a1 site📍 Shanghai Changhai Hospital · Tests: Endovascular treatment The STem Cell-derived Extracellular Vesicle Therapy In Acute Ischemic Stroke (STEVIA) NCT06995625Phase 13 sites📍 Suwon📍 Seoul📍 Seoul S&Ebio Co. Ltd. · Tests: SNE-101 Effect of Postoperative Prolonged Sedation With Dexmedetomidine After Successful Reperfusion With EVT on Long-term Prognosis in Patients With AIS (PPDET) NCT04916197Phase 41 site📍 Beijing Beijing Chao Yang Hospital · Tests: Dexmedetomidine prolonged sedation, 0.9% saline Human Placenta-derived 3D Mesenchymal Stem Cells(Guojianqingke) NCT07635758Phase 1, Phase 21 site📍 Beijing Chinese PLA General Hospital · Tests: Human Placenta-derived 3D Mesenchymal Stem Cells (Guojiangqingke) Balloon Guide Versus Conventional Guide Catheter in Stroke Thrombectomy NCT07085390NA2 sites📍 Tampa📍 Houston University of South Florida · Tests: Use of a Balloon Guide Catheter, Use of a Conventional (non-balloon) Guide Catheter Randomized Clinical Trial of Endovascular Therapy for Acute Ischemic Stroke With Occlusion of the M2 Segment of Middle Cerebral Artery NCT07347665NA3 sites📍 Nishinomiya📍 Khlong Luang📍 Can Tho Hyogo Medical University · Tests: Endovascular therapy Prospective Registry of Endovascular Thrombectomy for eXtra-Large Ischemic Stroke NCT06210633n/a1 site📍 Xiangtan Zhongming Qiu · Tests: medical management, endovascular thrombectomy Normobaric Oxygen in AIS Transferred for EVT NCT06666764Phase 3112 sites📍 Beijing📍 Fuzhou📍 Fuzhou Capital Medical University · Tests: NBO, Control Angong Niuhuang Pills With Different Bovine Bezoar Formulation Sources in the Treatment of AIS NCT06883110NA1 site📍 Wuhan Tongji Hospital · Tests: Z11020076, Z20063878 Mobilisation After Endovascular Stroke Treatment NCT07860333n/a2 sites📍 Tampere📍 Stockholm Karolinska Institutet · Tests: Mobilisation ACT-GLOBAL IA Thrombolysis(ACT-REACT-004)Domain Within the ACT-GLOBAL Adaptive Platform Trial-NCT06352632 NCT07687056Phase 313 sites📍 Sydney📍 Calgary📍 Edmonton University of Calgary · Tests: Tenecteplase or Alteplase- depending upon availability at each treating centre, Control Efficacy and Safety of LT3001 on Treating the Acute Ischemic Stroke NCT05686642Phase 228 sites📍 Beijing📍 Guangzhou📍 Luoyang Shanghai Pharmaceuticals Holding Co., Ltd · Tests: LT3001 Drug:high dose, Placebo, LT3001 Drug:low dose Pulse Endovascular ReperFUSION for Acute Ischemic Stroke NCT06052969NA1 site📍 Columbia Euphrates Vascular, Inc. · Tests: Pulse NanoMED System Comparison Influence to Prognosis of CTP and MRP in AIS Patients NCT03367286n/a1 site📍 Hangzhou Second Affiliated Hospital, Zhejiang University, School of … · Tests: inspection mode HBO After Thrombectomy for AIS With LVO NCT07626450NA1 site📍 Beijing Beijing Tiantan Hospital · Tests: Hyperbaric oxygen therapy plus standard medical treatment, Standard medical treatment Plaque Imaging in Routine Care to Detect Intraplaque Hemorrhage NCT06749106n/a1 site📍 Munich Ludwig-Maximilians - University of Munich
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy